XML 74 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation Plans
12 Months Ended
Dec. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Plans

10. Stock-Based Compensation Plans

The Company has a stock incentive plan which provides for the grant of stock options, stock appreciation rights, restricted stock, performance shares, performance units, or other stock-based awards as incentives and rewards to encourage employees, consultants and non-employee directors to participate in the long-term success of the Company. As of December 31, 2014, there were 988,059 shares available for grant under the stock incentive plan.

 

Total stock-based compensation expense was as follows:

 

 

 

Year Ended December 31,

 

 

 

 

2014

 

 

 

2013

 

 

 

2012

 

 

 

(In thousands)

 

Employee:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock and performance shares

 

$

8,193

 

 

$

7,269

 

 

$

7,046

 

Stock options

 

 

676

 

 

 

900

 

 

 

668

 

 

 

 

8,869

 

 

 

8,169

 

 

 

7,714

 

Non-employee directors:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock

 

 

900

 

 

 

710

 

 

 

671

 

Total stock-based compensation

 

$

9,769

 

 

$

8,879

 

 

$

8,385

 

The Company records stock-based compensation expense for employees in employee compensation and benefits and for non-employee directors in general and administrative expenses in the Consolidated Statements of Operations.

Stock Options

The exercise price of each option granted is equal to the market price of the Company’s common stock on the date of grant. Generally, option grants have provided for vesting over a three or five-year period. Options expire in ten years from the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. The determination of fair value of share-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables, including the expected stock price volatility over the term of the awards, the risk-free interest rate, the expected dividend yield rate and the expected term. Expected volatilities are based on historical volatility of the Company’s stock. The risk-free interest rate is based on U.S. Treasury securities with a maturity value approximating the expected term of the option.  The dividend yield rate is based on the expected annual dividends to be paid divided by the expected stock price. The expected term represents the period of time that options granted are expected to be outstanding based on actual and projected employee stock option exercise behavior.

The weighted-average fair value for options granted during 2014, 2013 and 2012 was $19.25, $19.61 and $12.26, respectively. The following table represents the assumptions used for the Black-Scholes option-pricing model to determine the per share weighted-average fair value for options granted for the three years ended December 31, 2014:

 

 

 

 

2014

 

 

 

2013

 

 

 

2012

 

Expected life (years)

 

 

5.0

 

 

 

9.9

 

 

 

5.0

 

Risk-free interest rate

 

 

1.7

%

 

 

1.9

%

 

 

0.7

%

Expected volatility

 

 

35.5

%

 

 

44.3

%

 

 

48.2

%

Expected dividend yield

 

 

1.0

%

 

 

1.2

%

 

 

1.2

%

The following table reports stock option activity during the three years ended December 31, 2014 and the intrinsic value as of December 31, 2014:

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

 

 

 

 

 

Shares

 

 

Exercise Price ($)

 

 

Term

 

 

Intrinsic Value ($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

 

Outstanding at December 31, 2011

 

 

2,927,737

 

 

 

9.42

 

 

 

 

 

 

 

 

 

Granted

 

 

13,292

 

 

 

32.45

 

 

 

 

 

 

 

 

 

Canceled

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(1,511,207

)

 

 

5.64

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2012

 

 

1,429,822

 

 

 

13.62

 

 

 

 

 

 

 

 

 

Granted

 

 

51,597

 

 

 

41.75

 

 

 

 

 

 

 

 

 

Canceled

 

 

(4,348

)

 

 

33.84

 

 

 

 

 

 

 

 

 

Exercised

 

 

(256,622

)

 

 

12.33

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2013

 

 

1,220,449

 

 

 

15.01

 

 

 

 

 

 

 

 

 

Granted

 

 

382

 

 

 

63.07

 

 

 

 

 

 

 

 

 

Canceled

 

 

(41,071

)

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(165,340

)

 

 

15.85

 

 

 

 

 

 

 

7,518

 

Outstanding at December 31, 2014

 

 

1,014,420

 

 

 

13.81

 

 

 

3.1

 

 

 

58,731

 

Exercisable at December 31, 2014

 

 

928,813

 

 

 

13.05

 

 

 

2.9

 

 

 

54,482

 

 

The intrinsic value is the amount by which the closing price of the Company’s common stock on December 31, 2014 of $71.71 or the price on the day of exercise exceeds the exercise price of the stock options multiplied by the number of shares. As of December 31, 2014, there was $0.4 million of total unrecognized compensation cost related to non-vested stock options. That cost is expected to be recognized over a weighted-average period of 1.0 years.

Restricted Stock and Performance Shares

Restricted stock generally vests over a three or five-year period. Compensation expense is measured at the grant date and recognized ratably over the vesting period. Performance share awards are granted to certain senior managers. Each performance share award is earned or forfeited based on the level of achievement by the Company of pre-tax operating income on a per share basis before performance share and cash bonus expense. The pay-out ranges from zero to 150% of the performance share award. For each performance share earned, a participant is awarded an equal number of shares of restricted stock. Any restricted stock awarded to a participant vests and ceases to be restricted stock in two equal installments on each of the second and third anniversaries of the date of grant of the applicable performance share award. Compensation expense for performance shares is measured at the grant date and recognized on a graded basis over the vesting period. The pay-out achievement was 85.0%, 108.0%, and 92.5% of the performance award for 2014, 2013 and 2012, respectively. The following table reports performance share activity for the three years ended December 31, 2014:

 

Performance year

 

2014

 

 

2013

 

 

2012

 

Share pay-out at plan

 

 

29,678

 

 

 

42,908

 

 

 

44,843

 

Actual share pay-out in following year

 

 

25,228

 

 

 

46,340

 

 

 

41,481

 

Fair value per share on grant date

 

$

63.07

 

 

$

35.98

 

 

$

30.64

 

 

The following table reports restricted stock and performance share activity during the three years ended December 31, 2014:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

Number of

 

 

Grant Date Fair

 

 

 

Restricted Shares

 

 

Value

 

Outstanding at December 31, 2011

 

 

957,711

 

 

$

15.69

 

Granted

 

 

206,965

 

 

 

 

 

Performance share pay-out

 

 

91,498

 

 

 

 

 

Canceled

 

 

(7,390

)

 

 

 

 

Vested

 

 

(497,525

)

 

 

 

 

Outstanding at December 31, 2012

 

 

751,259

 

 

$

21.88

 

Granted

 

 

255,266

 

 

 

 

 

Performance share pay-out

 

 

41,481

 

 

 

 

 

Canceled

 

 

(93,358

)

 

 

 

 

Vested

 

 

(384,914

)

 

 

 

 

Outstanding at December 31, 2013

 

 

569,734

 

 

$

31.86

 

Granted

 

 

149,349

 

 

 

 

 

Performance share pay-out

 

 

46,340

 

 

 

 

 

Canceled

 

 

(43,185

)

 

 

 

 

Vested

 

 

(286,249

)

 

 

 

 

Outstanding at December 31, 2014

 

 

435,989

 

 

$

41.83

 

 

As of December 31, 2014, there was $11.4 million of total unrecognized compensation expense related to non-vested restricted stock and performance shares. That cost is expected to be recognized over a weighted-average period of 1.5 years.